Cambridge researchers redesign future mRNA therapeutics
One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses
Read More
Tag: University of Kent
LifeArc inks pain medicine development deal with Uni of Kent
A minimum of two to three years’ work will be required before any small-molecule candidates are ready to enter clinical development.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
